Adagio Medical Holdings (ADGM) Shares Outstanding (Weighted Average) (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Shares Outstanding (Weighted Average) data on file, last reported at $22.2 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 44.45% year-over-year to $22.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.2 million (up 44.45% YoY) and the FY2025 annual result came in at $7.5 million, down 49.04% from the prior year.
• Shares Outstanding (Weighted Average) grew to $22.2 million in Q1 2026 per ADGM's latest filing, from $7.5 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $22.2 million in Q1 2026 and bottomed at $759489.0 in Q3 2023.
• The 4-year median for Shares Outstanding (Weighted Average) is $14.1 million (2024), against an average of $9.8 million.
• Peak annual rise in Shares Outstanding (Weighted Average) reached 1871.84% in 2025, while the deepest fall reached 49.04% in 2025.
• Tracing ADGM's Shares Outstanding (Weighted Average) over 4 years: stood at $759814.0 in 2023, then surged by 1844.25% to $14.8 million in 2024, then slumped by 49.04% to $7.5 million in 2025, then soared by 195.01% to $22.2 million in 2026.
• Per Business Quant, the three latest ADGM Shares Outstanding (Weighted Average) figures stand at $22.2 million (Q1 2026), $7.5 million (Q4 2025), and $15.4 million (Q3 2025).

Peer Comparison